Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Improving swallowing rehabilitation for stroke patients

Official title: Enhancing Post-Stroke Dysphagia Rehabilitation Via the Synergistic Effects of Neuromuscular Electrical Stimulation, Neuromuscular Taping, and Swallowing Exercises: a Randomized Controlled Trial

Run by Hamad Medical Corporation · NCT06887855 · Data updated 2026-11-12

This study is testing a new swallowing therapy that combines electrical stimulation, taping, and exercises to see if it helps stroke patients with swallowing difficulties more than just using one of those methods alone.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment10 (estimated)
SponsorHamad Medical Corporation
Industry-sponsored
Locations1 site (Doha, Baladiyat ad Dawhah)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedAugust 30, 2025
Study endsDecember 30, 2025
Registry record updatedMarch 20, 2025
Trial IDNCT06887855 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 75 who have been diagnosed with swallowing disorders within six months post-stroke and have not previously received swallowing treatment.

Probably not a fit

Patients with severe cognitive impairment or swallowing disorders due to other causes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of a combined swallowing intervention that includes Neuromuscular Electrical Stimulation (NMES), Neuromuscular Taping (NMT), and swallowing exercises on patients with dysphagia following a stroke. Participants will be randomly assigned to one of three groups to compare the effectiveness of the combined approach against NMES or NMT alone. The study will take place at Hamad Medical Corporation in Qatar, where participants will attend therapy sessions five times a week for two weeks. Evaluations will be conducted before and after the intervention to assess improvements in swallowing function and quality of life.

Why it matters

Potential benefit: If successful, this approach could significantly enhance swallowing function and quality of life for patients recovering from stroke-related dysphagia.

How similar studies have gone: Other studies have shown promising results with similar rehabilitation approaches, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 - 75 years old,
* Diagnosed with swallowing disorders between one day and six months post-stroke,
* Able to attend 10 therapy sessions,
* Have never received any swallowing treatment before participating in this study.

Exclusion Criteria:

* Post-stroke patients with severe cognitive impairment,
* Patients who have swallowing disorders due to other etiologies,
* Patients who need traditional swallowing therapy other than Expiratory Muscle Strength Training (EMST) and Chin Tuck Against Resistance (CTAR). - Skin disorders in the submental area and anterior neck,
* Medical conditions that may affect participation,
* A defibrillator and use precision electrical biomedical devices (e.g. pacemaker, etc.).

Where it's running

  • Hamad Medical Corporation
    Doha, Baladiyat ad Dawhah, Qatar
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.